The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mmmm , well our man AN intimated 2021 !, I cannot see a train of communication from fda / brokers note and AGL .
I appreciate that AIR was requested and perhaps if it’s been more patient data which agl control and know of then I think to an extent not necessarily wishful thinking but my own admittedly flawed logic from months ago which is the further from the fda submission we are nearer to a result .
Seen many brokers notes of different standards and levels ( whom sponsored those mentioned ?)
As you say one of the notes says Q1 which lasts another 57 days or so .
Hopefully we have news soon ( my telegram group guess was January , I think the biggest % of the group chose Feb, GLA )
AGL do not need to rely on The NHS as the American Market alone is beyond imagination as is The Asian , the former is part why of AGL operations in USA alone !
Well Two today , still awaiting the Big Kahuna .
So perhaps we’ve are still in AGL I , AGL II will be after The Big Kahuna , my own view is that AGL III the final of the trilogy will be a big buy out !
The ipo last 240 months ,,we are now in month 16 so the clicks ticking .
Northern Hemisphere in Winter , Lack of Significant reservoir maintenance, uncertain of recent inventories .
I have taken out a few ETF’s on Oil so in unison with my HUR holdings fingers crossed
Reasonably certain that certain Toolpushers , Drillers and Company Men would disagree with you .
A 90 % decrease ( yes overdone ) in assets and the current shareprice says it all .
Think with HUR the cult of ego took over and DrT was like many other recent failed CEO’s , tunnel visioned and aloof .
Harsh but true .
The irony here that the Pantomine villian Mr E has become Prince Charming .
Bought more recently based on price of oil and cash in the bank , with ongoing energy crisis mixed in my decison
Phantom brilliant reposte , I do not know .
It’s strange that the argument completely flip flops from being wrong priced to correctly or as is vice versa .
Because every day now is so tantalising nearer and nearer .
After a decade or so we are surely within spitting distance !
However I would be tempted to bank a few £k in the hope bizarrely enough that my lions share drop in value !
Outstanding point phantom bravo
The proof of the pudding , A Catch22 in reverse.
I bought more today and would gladly hopefully be wrong however ,
Logic being if an events happening date is unknown how can you put a pre price based on this unknown !?!
Yes definitely, no matter how much is said fda approval is the big difference , yes there probably are many more clinical contracts that may be waiting for approval to be completed but if you look at mcap v earnings how much is needed in clinical contracts to keep the current share price?
Nothing is certain and If kept in this price range there’s is the potential to increase greatly on approval .
Can posters see many more coming to the party before fda is given ?
Probably when derisked once given perhaps.
Another day nearer
Blah , strange one that one , effectively a reverse short position versus their pay structure .
That’s the thing , that many CEO’ s are paid mainly for failure , missed timelines ,,earnings etc and paid handsomely for it .
Uncertain as to how fully incentivise CEO’s to get everything they can out of a company at a set time and place in time for them .
Then looking at some NEDs there remuneration package versus days / hours worked ( I’m speaking in general here rather than just about AGL ) .
At a tangent football managers are akin , many fail but are both paid handsomely for it then get chance after chance , often think that there’s a conspiracy of the same people picking the same people ad infinatum.
Hi Chester , I postulated similar yesterday on the other site .
My own feelings are that unless fda approval is given we won’t get much above our highest share price .
Partly erring on side of caution If another delay or worse and the few current minuscule clinical deals aren’t priced in already so unless lots of deals come in and multiples of the previous ones then this £2 will not happen .
This is also bearing in mind that nobody knows if and when it will happen so it’s not as if a leaky ship ( none do far ) and massive buying takes the reins
I’d say that each ‘ filter ‘ will have its own serial number and bar code system with full provenance ie when built , where built possibly shelf life .
Where and when used and on whom will be added into the mix .
Also stock rotation etc .
Probably looked into by fda for such instances
I think it’s a second hand emotion !
Thing being these fda people have a horrific amount of responsibility with there jobs , so things like this is a fine tooth comb .
Yes admittedly a request for more data which was given , hopefully soon we will be grateful for this delay as it’s allowed us to buy many more .